Insilicos, a Seattle-based developer of biomedical software and diagnostics, has secured a $1.2 million grant from the National Institutes of Health, through the Small Business Innovation Research program, to study a potential new test for people with chest pain. The test will be given to 400 patients at the University of Washington with cardiovascular disease, and will attempt to predict whether they will suffer heart attacks. “People who can’t be diagnosed can’t benefit from treatment. For this and other reasons, diagnostics are, in my opinion, the greatest need and greatest opportunity in cardiovascular disease, and it feels great to take a big step towards doing something about that,” Insilicos president Erik Nilsson says in an e-mail.
